Tuesday, February 10, 2026 | 04:03 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap(    %)
                             
Nifty Smallcap(    %)
                             
Nifty Bank(    %)
                             
Nifty IT(    %)
                             
Home / Markets / Fredun Pharmaceuticals Ltd

Fredun Pharmaceuticals Share Price

Know More
BSENSE

₹1,796.60 148.60 (9.02%)

04:01 PM, 9-Feb-2026
Stock not traded

BSE : 539730

Sector : Health care

ISIN Code : INE194R01017

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 09-Feb-2026 | 04:01 PM IST

Add to PortfolioAdd to Watchlist

Market Cap (₹ Cr)

965

Traded Value (₹ Cr)

5.37

Volume (Shares)

29,901

Face Value (₹)

10

52-Week High (₹)

1,999.00

52-Week High Date

02-Dec-2025

52-Week Low (₹)

635.05

52-Week Low Date

09-Apr-2025

All Time High (₹)

1,999.00

All Time High Date

02-Dec-2025

All Time Low (₹)

12.50

All Time Low Date

28-Mar-2016

Fredun Pharmaceuticals Ltd

Incorporated in 1987 as a private limited company Fredun Pharmaceuticals Limited (FPL) was converted into a public limited company in Mar.'94. The Company was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma a proprietary firm for the manufacture and export of pharmaceutical formulations. Since 1993 D...
Read More

Market News

More

Fredun Pharma Announcement

Revised Outcome

Intimation of Earnings Conference Call for the quarter ended 31st December 2025.

Un-Audited Financial Results of the Company for the Quarter and Nine Months Ended 31st December 2025

Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Monday February 09 2026 has inter-alia considered adopted and approved following business item: 1. In compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Un-Audited Financial Results of the Company for the Quarter and Nine Months Ended 31st December 2025 along with the Limited Review Report as issued by M/s. R.H. Nisar & Co Statutory Auditors of the Company; copies of which are attached hereunder; In furtherance to the intimation filed by the Company dated January 30 2026; the trading window for trading in securities of the Company by designated persons and their immediate relatives closed on January 01 2026 till the end of 48 hours after the declaration of outcome of Board Meeting.

Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve Intimation is hereby given pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the meeting of the Board of Directors of Fredun Pharmaceuticals Limited is scheduled to be held on Monday 09th February 2026 inter-alia to consider and approve the following:a) Un-audited Financial Results (Standalone & Consolidated) of the Company for Third Quarter and Nine months ended 31st December 2025.

More

Fredun Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

965

EPS - TTM (₹) [C]

60.90

P/E Ratio (X) [C]

29.50

Face Value (₹) 10
Latest Dividend (%)7.00
Latest Dividend Date 23-Sep-2025
Dividend Yield (%) 0.03
Book Value Share (₹) [C]443.15
P/B Ratio (₹) [C]4.05

[*C] Consolidated [*S] Standalone

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Data Not Found

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

1,672.00

1,842.00

Week Low/High (₹)

1,508.00

1,842.00

Month Low/High (₹)

1,362.15

1,842.00

Year Low/High (₹)

635.05

1,999.00

All time Low/High (₹)

12.50

1,999.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week12.63%-2.94%3.10%
1 Month25.02%-0.59%0.72%
3 Month15.81%-1.02%1.47%
6 Month69.59%-5.27%6.17%
1 Year147.67%-7.97%9.79%
3 Year79.80%-38.25%44.56%

Company Info

Company Information

Chairperson & Joint MD : Daulat N Medhora

Non Executive Director : Nariman B Medhora

Non Executive & Independent Director : Aspi N Raimalwala

Managing Director & CFO : Fredun N Medhora

Non Executive & Independent Director : Rohinton Kanga

Non Executive & Independent Director : Daisy Dsouza

Independent Director : Anshu Agarwal

Independent Director : Sonal Desai

Registered Office: 26 Manoj Industrial Premises, G D Ambedkar Marg Wadala,Mumbai,Maharashtra-400031 Ph: 91-22-40318111

Email:business@fredungroup.com

URL:http://www.fredungroup.com

FAQs about Fredun Pharmaceuticals Ltd

1. What's the Fredun Pharmaceuticals Ltd share price today?
Fredun Pharmaceuticals Ltd share price was Rs 1,796.60 at 04:01 PM IST on 9th Feb 2026. Fredun Pharmaceuticals Ltd share price was up by 9.02% over the previous closing price of Rs 1,648.00. Fredun Pharmaceuticals Ltd share price trend:

  • Last 1 Month: Fredun Pharmaceuticals Ltd share price moved up by 25.02% on BSE.
  • Last 3 Months: Fredun Pharmaceuticals Ltd share price moved up by 15.81% on BSE.
  • Last 12 Months: Fredun Pharmaceuticals Ltd share price moved up by 147.67% on BSE.
  • Last 3 Years: Fredun Pharmaceuticals Ltd share price moved up by 79.80% on BSE.


2. How can I quickly analyse the performance of the Fredun Pharmaceuticals Ltd stock?
The performance of the Fredun Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 29.50
  • Price to book value ratio is 4.05
  • Dividend yield of 0.03
  • The EPS (trailing 12 months) of the Fredun Pharmaceuticals Ltd stock is Rs 60.90


3. What is the market cap of Fredun Pharmaceuticals Ltd?
Fredun Pharmaceuticals Ltd has a market capitalisation of Rs 965 crore.


4. What is Fredun Pharmaceuticals Ltd's 52-week high/low share price?
The Fredun Pharmaceuticals Ltd’s 52-week high share price is Rs 1,999.00 and 52-week low share price is Rs 635.05.


5. Is the Fredun Pharmaceuticals Ltd profitable?
On a consolidated basis, Fredun Pharmaceuticals Ltd reported a profit of Rs 9.43 crore on a total income of Rs 145.29 crore for the quarter ended 2025.


6. Which are Fredun Pharmaceuticals Ltd’s peers in the Health care sector?
Fredun Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Ind-Swift Labs., Lincoln Pharma., Sigachi Indust., Fredun Pharma, Fermenta Biotec., Venus Remedies, Wanbury.


7. Who owns how much in Fredun Pharmaceuticals Ltd?
Key changes to the Fredun Pharmaceuticals Ltd shareholding are as follows:

  • Promoter holding in Fredun Pharmaceuticals Ltd has gone down to 43.06 per cent as of Dec 2025 from 48.93 per cent as of Jun 2025.